| Literature DB >> 33553724 |
Zakari Ya'u Ibrahim1, Adamu Uzairu1, Gideon Adamu Shallangwa1, Stephen Eyije Abechi1.
Abstract
Resistance nature of Plasmodium falciparum (P. falciparum) to the most effective antimalarial drug, Artemisinin, intimidate the global goal of total eradication of malarial. In an attempt to overcome this challenge, the research was aimed at designing derivatives of β-amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles with improve activity against the P. falciparum through structural modifications of the most active compound (design template), and their activity determined using the developed theoretical predictive model. To achieve this, the geometries were optimized via density functional theory (DFT) using B3LYP/6-31G∗ basis set to generate molecular descriptors for model development. Analysis of the developed model and the descriptors mean effect lead to the design of derivatives with improved activity. Five (5) theoretical models were developed, where the model {pIC50 = 5.95067(SpMin5_Bhi) - 0.0323461(RDF45m) + 0.0203865 (RDF95e) + 0.0499285 (L1m) - 3.50822} with the highest coefficient of determination (R2) of 0.9367, cross-validated R2 (Q2cv) of 0.8242, and the external validated R2 (R2 pred) of 0.9462, selected as the best model. The mean effect analysis revealed descriptor SpMin5_Bhi as the most contributive. The descriptor encodes the first ionization potentials of the compounds and are influenced by electron-withdrawing/donating substituents. Hence, structural modifications of the compound with the highest activity (a design template) using electron-withdrawing substituents such as -NO2, -SO3H, -Br, -I, -CH2CH3, and -CH3 was done at a different positions, to obtain five (5) hypothetical novel compounds. The statistical results, shows the robustness, excellent prediction power, and validity of the selected model. Descriptor analysis revealed the first ionization potential (SpMin5_Bhi) to play a significant role in the activity of β-amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles derivatives. The five design derivatives of β-amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles with higher activities revealed compound 21C to have an antimalarial activity of pIC50 = 6.7573 higher than it co-designed compounds and even the standard drug. This claim could be verified through molecular docking to determine their interaction with the target protein.Entities:
Keywords: Antimalarial agent; Design; First ionization potential; GFA; Molecular descriptors; Molecular modeling; Plasmodium falciparum; β-Amino alcohol grafted 1,4,5-trisubstituted 1, 2, 3-triazoles
Year: 2021 PMID: 33553724 PMCID: PMC7851792 DOI: 10.1016/j.heliyon.2021.e05924
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Chemical structures and activities of β-amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles derivatives against Chloroquine sensitive (3D7) strain.
| Compounds | Structures | IC50 (μM) | pIC50 |
|---|---|---|---|
| 1 | 1.48 | 5.8297 | |
| 2 | 1.33 | 5.8761 | |
| 3 | 2.15 | 5.6676 | |
| 4 | 2.24 | 5.6498 | |
| 5 | 2.73 | 5.5638 | |
| 6 | 1.65 | 5.7825 | |
| 7 | 2.42 | 5.6162 | |
| 8 | 2.71 | 5.5670 | |
| 9 | 1.65 | 5.7825 | |
| 10 | 2.72 | 5.5654 | |
| 11 | 3.21 | 5.4935 | |
| 12 | 0.87 | 6.0605 | |
| 13 | 3.31 | 5.4802 | |
| 14 | 1.95 | 5.7100 | |
| 15 | 2.58 | 5.5884 | |
| 16 | 3.87 | 5.4123 | |
| 17 | 2.85 | 5.5452 | |
| 18 | 1.10 | 5.9586 | |
| 19 | 2.67 | 5.5735 | |
| 20 | 1.58 | 5.8013 | |
| 21 | 0.30 | 6.5229 | |
| 22 | 1.78 | 5.7496 | |
| 23 | 11.57 | 4.9367 | |
| 24 | 9.09 | 5.0414 |
Parameters of validating the developed models.
| Parameters | |||||
|---|---|---|---|---|---|
| Friedman LOF | 0.0276 | 0.0314 | 0.0329 | 0.0338 | 0.0272 |
| R-squared (R2) | 0.8937 | 0.9367 | 0.9337 | 0.9318 | 0.8952 |
| Adjusted R-squared (R2adj) | 0.8709 | 0.9172 | 0.9134 | 0.9108 | 0.8728 |
| Cross validated R-squared (Q2cv) | 0.8109 | 0.8242 | 0.8609 | 0.8387 | 0.8203 |
| External Validated R2 (R2pred) | 0.7953 | 0.9462 | 0.7948 | 0.8502 | 0.7612 |
| Significant Regression | Yes | Yes | Yes | Yes | Yes |
| Significance-of-regression F-value | 39.2229 | 48.1064 | 45.80158 | 44.40638 | 39.88006 |
| Critical SOR F-value (95%) | 3.5032 | 3.2266 | 3.226561 | 3.226561 | 3.503249 |
| Replicate points | 0 | 0 | 0 | 0 | 0 |
| Computed experimental error | 0 | 0 | 0 | 0 | 0 |
| Lack-of-fit points | 14 | 13 | 13 | 13 | 14 |
| Min expt. error for non-significant LOF (95%) | 0.0790 | 0.0627 | 0.064165 | 0.065098 | 0.078407 |
∗The criteria for model acceptability is: R2 ≥ 0.6 (Alexander et al., 2015).
Correlation matrix of the model descriptors and their VIF.
| SpMin5_Bhi | RDF45m | RDF95e | L1m | ||
|---|---|---|---|---|---|
| SpMin5_Bhi | 1 | 1.8640 | |||
| RDF45m | 0.039292 | 1 | 1.0731 | ||
| RDF95e | 0.605871 | -0.07456 | 1 | 1.7720 | |
| L1m | 0.246993 | 0.256237 | -0.10207 | 1 | 1.2577 |
Figure 1Experimental activity plotted against predicted activity for the entire dataset.
Comparison of Experimental, predicted and residual of the data set.
| S/N | Experimental pIC50 | Predicted pIC50 | Residual |
|---|---|---|---|
| 1 | 5.8297 | 5.8745 | -0.0448 |
| 2 | 5.8761 | 5.7121 | 0.1640 |
| 3 | 5.6676 | 5.5905 | 0.0771 |
| 4 | 5.6498 | 5.6495 | 0.0003 |
| 5 | 5.5638 | 5.5250 | 0.0388 |
| 6 | 5.7825 | 5.8204 | -0.0379 |
| 7 | 5.6162 | 5.6255 | -0.0093 |
| 8 | 5.5670 | 5.5742 | -0.0072 |
| 9 | 5.7825 | 5.8070 | -0.0245 |
| 10∗ | 5.5654 | 5.7177 | -0.1523 |
| 11∗ | 5.4935 | 5.6162 | -0.1227 |
| 12∗ | 6.0605 | 5.8913 | 0.1692 |
| 13 | 5.4802 | 5.4449 | 0.0353 |
| 14 | 5.7100 | 5.7575 | -0.0475 |
| 15 | 5.5884 | 5.6277 | -0.0393 |
| 16 | 5.4123 | 5.4623 | -0.0500 |
| 17 | 5.5452 | 5.4677 | 0.0775 |
| 18∗ | 5.9586 | 5.7926 | 0.1660 |
| 19 | 5.5735 | 5.6407 | -0.0672 |
| 20 | 5.8013 | 5.9514 | -0.1501 |
| 21 | 6.5229 | 6.4282 | 0.0947 |
| 22∗ | 5.7496 | 5.6820 | 0.0676 |
| 23∗ | 4.9367 | 5.3807 | -0.4440 |
| 24 | 5.0414 | 5.0514 | -0.0100 |
NB: ∗ Test Sets.
Figure 2The plot of the standardized residuals vs. leverages (Williams plot).
Figure 33-D pie mean effect of descriptors.
Figure 4Designed Compound Template, 1-(1-benzyl-5-(4-isopropylphenyl)-1H-1,2,3-triazol-4-yl)-2-((4-bromophenyl)amino)-1-(4-chlorophenyl)ethanol, pIC50 = 6.5229.
Molecular structures of design β-amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles derivatives and their hypothetical activities.
| S/N | STRUCTURES | pIC50 |
|---|---|---|
| 21A | 6.7532 | |
| 21B | 6.7449 | |
| 21C | 6.7573 | |
| 21D | 6.6056 | |
| 21E | 6.7428 | |
| Chloroquine Standard | 3.5579 |